Perioperative Considerations for Hysterectomy in Second-Trimester Molar Pregnancy
Second-trimester complete molar pregnancies are rare. Due to a later presentation, means to reduce surgical and long-term morbidity from hemorrhage, hyperthyroidism, and gestational trophoblastic neoplasia risk should be considered. A 48-year-old woman presented at 17 6/7 weeks of gestation with vag...
Gespeichert in:
Veröffentlicht in: | Obstetrics and gynecology (New York. 1953) 2023-07, Vol.142 (1), p.211-214 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 214 |
---|---|
container_issue | 1 |
container_start_page | 211 |
container_title | Obstetrics and gynecology (New York. 1953) |
container_volume | 142 |
creator | Applebaum, Jeremy Mulugeta-Gordon, Lakeisha Mokkarala, Sameera Salva, Catherine R. |
description | Second-trimester complete molar pregnancies are rare. Due to a later presentation, means to reduce surgical and long-term morbidity from hemorrhage, hyperthyroidism, and gestational trophoblastic neoplasia risk should be considered.
A 48-year-old woman presented at 17 6/7 weeks of gestation with vaginal bleeding, with a human chorionic gonadotropin (hCG) level of 483,906 milli-international units/mL, biochemical hyperthyroidism, and ultrasonographic suspicion for complete molar pregnancy. The patient received preoperative uterine artery embolization and antithyroid medication before undergoing total abdominal hysterectomy. Her thyroid function and hCG level normalized by 1 week and 69 days postoperatively, respectively.
Uterine artery embolization and hysterectomy may reduce surgical blood loss and lower the risk of malignancy for patients at high risk for gestational trophoblastic neoplasia. Preoperative treatment of hyperthyroidism with gestational trophoblastic disease can reduce morbidity from thyrotoxicosis. |
doi_str_mv | 10.1097/AOG.0000000000005214 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2829425983</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2829425983</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3524-169d2d3c86d31096561bd93ed966ad55d70b7c1d25ed6c7dced15c7bf06268c73</originalsourceid><addsrcrecordid>eNpdkF1LwzAUhoMobk7_gUgvvenMR5O0l2PoJkw2cYJ3pU1OXbVrZtI69u_NPvzAQMg55D1v3jwIXRLcJziRN4PpqI__LE5JdIS6JJYspIy9HKMuxjQJZRxFHXTm3JsXEZGwU9RhkkUxTkQXPc7AlmYFNmvKTwiGpnal3nW-Cgpjg_HGNWBBNWa5Cco6eAJlah3ObbmE7U3wYKrMBjMLr3VWq805OimyysHF4eyh57vb-XAcTqaj--FgEirGaRT6JJpqpmKhmf-P4ILkOmGgEyEyzbmWOJeKaMpBCyW1Ak24knmBBRWxkqyHrve-K2s-Wh8lXZZOQVVlNZjWpTSmSUR5EjMvjfZSZY1zFop05dNndpMSnG5hph5m-h-mH7s6vNDmS9A_Q9_0fn3XpvIk3HvVrsGmC8iqZrHzE5TjkGLKsPRd6DeN2Be4Qn-5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2829425983</pqid></control><display><type>article</type><title>Perioperative Considerations for Hysterectomy in Second-Trimester Molar Pregnancy</title><source>Journals@Ovid Complete</source><creator>Applebaum, Jeremy ; Mulugeta-Gordon, Lakeisha ; Mokkarala, Sameera ; Salva, Catherine R.</creator><creatorcontrib>Applebaum, Jeremy ; Mulugeta-Gordon, Lakeisha ; Mokkarala, Sameera ; Salva, Catherine R.</creatorcontrib><description>Second-trimester complete molar pregnancies are rare. Due to a later presentation, means to reduce surgical and long-term morbidity from hemorrhage, hyperthyroidism, and gestational trophoblastic neoplasia risk should be considered.
A 48-year-old woman presented at 17 6/7 weeks of gestation with vaginal bleeding, with a human chorionic gonadotropin (hCG) level of 483,906 milli-international units/mL, biochemical hyperthyroidism, and ultrasonographic suspicion for complete molar pregnancy. The patient received preoperative uterine artery embolization and antithyroid medication before undergoing total abdominal hysterectomy. Her thyroid function and hCG level normalized by 1 week and 69 days postoperatively, respectively.
Uterine artery embolization and hysterectomy may reduce surgical blood loss and lower the risk of malignancy for patients at high risk for gestational trophoblastic neoplasia. Preoperative treatment of hyperthyroidism with gestational trophoblastic disease can reduce morbidity from thyrotoxicosis.</description><identifier>ISSN: 0029-7844</identifier><identifier>EISSN: 1873-233X</identifier><identifier>DOI: 10.1097/AOG.0000000000005214</identifier><identifier>PMID: 37348096</identifier><language>eng</language><publisher>United States: Lippincott Williams & Wilkins</publisher><ispartof>Obstetrics and gynecology (New York. 1953), 2023-07, Vol.142 (1), p.211-214</ispartof><rights>Lippincott Williams & Wilkins</rights><rights>Copyright © 2023 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3524-169d2d3c86d31096561bd93ed966ad55d70b7c1d25ed6c7dced15c7bf06268c73</citedby><cites>FETCH-LOGICAL-c3524-169d2d3c86d31096561bd93ed966ad55d70b7c1d25ed6c7dced15c7bf06268c73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37348096$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Applebaum, Jeremy</creatorcontrib><creatorcontrib>Mulugeta-Gordon, Lakeisha</creatorcontrib><creatorcontrib>Mokkarala, Sameera</creatorcontrib><creatorcontrib>Salva, Catherine R.</creatorcontrib><title>Perioperative Considerations for Hysterectomy in Second-Trimester Molar Pregnancy</title><title>Obstetrics and gynecology (New York. 1953)</title><addtitle>Obstet Gynecol</addtitle><description>Second-trimester complete molar pregnancies are rare. Due to a later presentation, means to reduce surgical and long-term morbidity from hemorrhage, hyperthyroidism, and gestational trophoblastic neoplasia risk should be considered.
A 48-year-old woman presented at 17 6/7 weeks of gestation with vaginal bleeding, with a human chorionic gonadotropin (hCG) level of 483,906 milli-international units/mL, biochemical hyperthyroidism, and ultrasonographic suspicion for complete molar pregnancy. The patient received preoperative uterine artery embolization and antithyroid medication before undergoing total abdominal hysterectomy. Her thyroid function and hCG level normalized by 1 week and 69 days postoperatively, respectively.
Uterine artery embolization and hysterectomy may reduce surgical blood loss and lower the risk of malignancy for patients at high risk for gestational trophoblastic neoplasia. Preoperative treatment of hyperthyroidism with gestational trophoblastic disease can reduce morbidity from thyrotoxicosis.</description><issn>0029-7844</issn><issn>1873-233X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpdkF1LwzAUhoMobk7_gUgvvenMR5O0l2PoJkw2cYJ3pU1OXbVrZtI69u_NPvzAQMg55D1v3jwIXRLcJziRN4PpqI__LE5JdIS6JJYspIy9HKMuxjQJZRxFHXTm3JsXEZGwU9RhkkUxTkQXPc7AlmYFNmvKTwiGpnal3nW-Cgpjg_HGNWBBNWa5Cco6eAJlah3ObbmE7U3wYKrMBjMLr3VWq805OimyysHF4eyh57vb-XAcTqaj--FgEirGaRT6JJpqpmKhmf-P4ILkOmGgEyEyzbmWOJeKaMpBCyW1Ak24knmBBRWxkqyHrve-K2s-Wh8lXZZOQVVlNZjWpTSmSUR5EjMvjfZSZY1zFop05dNndpMSnG5hph5m-h-mH7s6vNDmS9A_Q9_0fn3XpvIk3HvVrsGmC8iqZrHzE5TjkGLKsPRd6DeN2Be4Qn-5</recordid><startdate>20230701</startdate><enddate>20230701</enddate><creator>Applebaum, Jeremy</creator><creator>Mulugeta-Gordon, Lakeisha</creator><creator>Mokkarala, Sameera</creator><creator>Salva, Catherine R.</creator><general>Lippincott Williams & Wilkins</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20230701</creationdate><title>Perioperative Considerations for Hysterectomy in Second-Trimester Molar Pregnancy</title><author>Applebaum, Jeremy ; Mulugeta-Gordon, Lakeisha ; Mokkarala, Sameera ; Salva, Catherine R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3524-169d2d3c86d31096561bd93ed966ad55d70b7c1d25ed6c7dced15c7bf06268c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Applebaum, Jeremy</creatorcontrib><creatorcontrib>Mulugeta-Gordon, Lakeisha</creatorcontrib><creatorcontrib>Mokkarala, Sameera</creatorcontrib><creatorcontrib>Salva, Catherine R.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Obstetrics and gynecology (New York. 1953)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Applebaum, Jeremy</au><au>Mulugeta-Gordon, Lakeisha</au><au>Mokkarala, Sameera</au><au>Salva, Catherine R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Perioperative Considerations for Hysterectomy in Second-Trimester Molar Pregnancy</atitle><jtitle>Obstetrics and gynecology (New York. 1953)</jtitle><addtitle>Obstet Gynecol</addtitle><date>2023-07-01</date><risdate>2023</risdate><volume>142</volume><issue>1</issue><spage>211</spage><epage>214</epage><pages>211-214</pages><issn>0029-7844</issn><eissn>1873-233X</eissn><abstract>Second-trimester complete molar pregnancies are rare. Due to a later presentation, means to reduce surgical and long-term morbidity from hemorrhage, hyperthyroidism, and gestational trophoblastic neoplasia risk should be considered.
A 48-year-old woman presented at 17 6/7 weeks of gestation with vaginal bleeding, with a human chorionic gonadotropin (hCG) level of 483,906 milli-international units/mL, biochemical hyperthyroidism, and ultrasonographic suspicion for complete molar pregnancy. The patient received preoperative uterine artery embolization and antithyroid medication before undergoing total abdominal hysterectomy. Her thyroid function and hCG level normalized by 1 week and 69 days postoperatively, respectively.
Uterine artery embolization and hysterectomy may reduce surgical blood loss and lower the risk of malignancy for patients at high risk for gestational trophoblastic neoplasia. Preoperative treatment of hyperthyroidism with gestational trophoblastic disease can reduce morbidity from thyrotoxicosis.</abstract><cop>United States</cop><pub>Lippincott Williams & Wilkins</pub><pmid>37348096</pmid><doi>10.1097/AOG.0000000000005214</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0029-7844 |
ispartof | Obstetrics and gynecology (New York. 1953), 2023-07, Vol.142 (1), p.211-214 |
issn | 0029-7844 1873-233X |
language | eng |
recordid | cdi_proquest_miscellaneous_2829425983 |
source | Journals@Ovid Complete |
title | Perioperative Considerations for Hysterectomy in Second-Trimester Molar Pregnancy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T19%3A37%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Perioperative%20Considerations%20for%20Hysterectomy%20in%20Second-Trimester%20Molar%20Pregnancy&rft.jtitle=Obstetrics%20and%20gynecology%20(New%20York.%201953)&rft.au=Applebaum,%20Jeremy&rft.date=2023-07-01&rft.volume=142&rft.issue=1&rft.spage=211&rft.epage=214&rft.pages=211-214&rft.issn=0029-7844&rft.eissn=1873-233X&rft_id=info:doi/10.1097/AOG.0000000000005214&rft_dat=%3Cproquest_cross%3E2829425983%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2829425983&rft_id=info:pmid/37348096&rfr_iscdi=true |